Boujon, Valérie
Uhlemann, Ria
Wegner, Stephanie
Wright, Matthew B.
Laufs, Ulrich
Endres, Matthias
Kronenberg, Golo
Gertz, Karen
Funding for this research was provided by:
DFG (Exc257, KR 2956/4-1, GE 2576/2-1)
Bundesministerium für Bildung und Forschung (CSB)
DZNE (n.a.)
DZHK (n.a.)
Corona Foundation (n.a.)
F. Hoffmann-La Roche (n.a.)
Article History
Received: 14 August 2018
Revised: 17 May 2019
Accepted: 21 May 2019
First Online: 30 May 2019
Compliance with ethical standards
: All animal studies and experimental procedures were approved by the necessary official committees and conducted in compliance with the requirements set out in the European Communities Council Directive of November 24, 1986 (86/609/EEC) and the ARRIVE guidelines [CitationRef removed].
: As indicated above, this study was supported by a research grant from Roche (to M.E and K.G.). Aleglitazar (PubChem CID: 10274777) was kindly provided by Roche (Basel, Switzerland). Roche did not play a role in the conduct of the experiments reported here, nor in the collection, analysis, or interpretation of the data, nor in the preparation of this manuscript.